High-risk sexual behavior in adults with genotypically proven antiretroviral-resistant HIV infection

Journal of Acquired Immune Deficiency Syndromes

Volumn 40, Issue 4, 2005, Pages 463-471

  Chin Hong, Peter V ^a,d   Deeks, Steven G ^a   Liegler, Teri ^b   Hagos, Elilta ^a   Krone, Melissa R ^c   Grant, Robert M ^a,b   Martin, Jeffrey N ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Drug resistant HIV; HIV transmission; Risk behavior

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SILDENAFIL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENOTYPE; HETEROSEXUALITY; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; ALCOHOLISM; ANTI-HIV AGENTS; DEPRESSION; DRUG RESISTANCE, VIRAL; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEEDLE SHARING; PIPERAZINES; PLASMA; QUESTIONNAIRES; RISK-TAKING; RNA, VIRAL; UNSAFE SEX;

EID: 27944445367     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000162238.93988.0c     Document Type: Article

References (38)

1. Grant RM, Hecht FM, Warmerdam M, et al. Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA. 2002;288:181-188.
2. Little SJ, Holte S, Routy JP, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med. 2002;347:385-394.
3. Wensing AMJ, van de Vijver DAMC, Asjo B, et al. Analysis from more than 1600 newly diagnosed patients with HIV from 17 European countries shows that 10% of the patients carry primary drug resistance: the CATCH-Study. Paper presented at: 2nd IAS Conference on HIV Pathogenesis and Treatment, 2003; Paris, France.
4. Blower S. Calculating the consequences: HAART and risky sex. AIDS. 2001;15:1309-1310.
5. Blower SM, Aschenbach AN, Gershengorn HB, et al. Predicting the unpredictable: transmission of drug-resistant HIV Nat Med. 2001;7:1016-1020.
6. Blower SM, Gershengorn HB, Grant RM. A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science. 2000;287:650-654.
7. Law MG, Prestage G, Grulich A, et al. Modelling HIV incidence in gay men: increased treatment, unsafe sex and sexually transmissible infections. AIDS. 2002;16:499-501.
8. Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA. 2004;292:224-236.
9. Ostrow DE, Fox KJ, Chmiel JS, et al. Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men. AIDS. 2002;16:775-780.
10. Ekstrand ML, Stall RD, Paul JP, et al. Gay men report high rates of unprotected anal sex with partners of unknown or discordant HIV status. AIDS. 1999;13:1525-1533.
11. Koblin BA, Chesney MA, Husnik MJ, et al. High-risk behaviors among men who have sex with men in 6 US cities: baseline data from the EXPLORE Study. Am J Public Health. 2003;93:926-932.
12. Centers for Disease Control and Prevention, Health Resources and Services Administration, National Institutes of Health, HIV Medicine Association of the Infectious, Diseases Society of America. Incorporating HIV prevention into the medical care of persons living with HIV. Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2003;52(RR-12):1-24.
13. Katz MH, Schwarcz SK, Kellogg TA, et al. Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health. 2002;92:388-394.
14. Chen SY, Gibson S, Katz MH, et al. Continuing increases in sexual risk behavior and sexually transmitted diseases among men who have sex with men: San Francisco, Calif, 1999-2001, USA. Am J Public Health. 2002;92:1387-1388.
15. Sethi AK, Celentano DD, Gange SJ, et al. High-risk behavior and potential transmission of drug-resistant HIV among injection drug users. J Acquir Immune Defic Syndr. 2004;35:503-510.
16. Kozal MJ, Amico KR, Chiarella J, et al. Antiretroviral resistance and high-risk transmission behavior among HIV-positive patients in clinical care. AIDS. 2004;18:2185-2189.
17. Kozal M, Amico R, Chiarella J, et al. Continuing high-risk sexual behavior and increasing antiretroviral resistance among HIV+ patients in care helps explain the rising prevalence of resistance among new HIV infections [abstract 35LB]. Paper presented at: 11th Conference on Retroviruses and Opportunistic Infections, 2004; San Francisco, CA, USA.
18. Centers for Disease Control and Prevention. Increases in HIV diagnoses - 29 States, 1999-2002. MMWR Morb Mortal Wkly Rep. 2003;52:1145-1148.
19. Advancing HIV prevention. New strategies for a changing epidemic - United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:329-332.
20. US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Available at: http://www.aidsinfo.nih.gov/guidelines/. Accessed October 18, 2004.
21. Johnson VA, Brun-Vezinet F, Clotet B, et al. Drug resistance mutations in HIV-1. Top HIV Med. 2003;11:215-221.
22. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342:921-929.
23. Leigh Brown AJ, Frost SD, Mathews WC, et al. Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population. J Infect Dis. 2003;187:683-686.
24. Morin SF, Koester KA, Steward WT, et al. Missed opportunities: prevention with HIV-infected patients in clinical care settings. J Acquir Immune Defic Syndr. 2004;36:960-966.
25. Dukers NH, Goudsmit J, de Wit JB, et al. Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection. AIDS. 2001;15:369-378.
26. Chen SY, Weide D, McFarland W. Are the recent increases in sexual risk behavior among older or younger men who have sex with men? Answer: both. AIDS. 2003;17:942-943.
27. Starace F, Ammassari A, Trotta MP, et al. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S136-S139.
28. Tucker JS, Burnam MA, Sherbourne CD, et al. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114:573-580.
29. Wilson TE, Barron Y, Cohen M, et al. Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis. 2002;34:529-534.
30. Kalichman SC, Rompa D. HIV treatment adherence and unprotected sex practices in people receiving antiretroviral therapy. Sex Transm Infect. 2003;79:59-61.
31. Colfax GN, Mansergh G, Guzman R, et al. Drug use and sexual risk behavior among gay and bisexual men who attend circuit parties: a venue-based comparison. J Acquir Immune Defic Syndr. 2001;28:373-379.
32. Kim AA, Kent CK, Klausner JD. Increased risk of HIV and sexually transmitted disease transmission among gay or bisexual men who use Viagra, San Francisco 2000-2001. AIDS. 2002;16:1425-1428.
33. Chu PL, McFarland W, Gibson S, et al. Viagra use in a community-recruited sample of men who have sex with men, San Francisco. J Acquir Immune Defic Syndr. 2003;33:191-193.
34. McConnell J, Grant RM. Sorting out serosorting with sexual network methods [abstract 41]. Paper presented at: 10th Conference on Retroviruses and Opportunistic Infections, 2003; Boston, MA, USA.
35. Jost S, Bernard MC, Kaiser L, et al. A patient with HIV-1 superinfection. N Engl J Med. 2002;347:731-736.
36. Goulder PJ, Walker BD. HIV-1 superinfection - a word of caution. N Engl J Med. 2002;347:756-758.
37. Elford J, Bolding G, Sherr L. High-risk sexual behaviour increases among London gay men between 1998 and 2001: what is the role of HIV optimism? AIDS. 2002;16:1537-1544.
38. Stockman JK, Schwarcz SK, Butler LM, et al. HIV prevention fatigue among high-risk populations in San Francisco. J Acquir Immune Defic Syndr. 2004;35:432-434.